Objective Clinicians frequently rely on office blood pressure (BP) measurements alone to assess hypertension control, despite widespread acceptance of 24-h ambulatory blood pressure monitoring (ABPM) as the reference standard in the initial diagnosis of hypertension. This study was designed to investigate how often the hypertensive status differed between concurrent office BP versus ABPM measurements, and whether any patient-specific characteristics predict the risk for misclassification by office BP.
Introduction
Childhood hypertension is a growing epidemic that will likely result in increased adverse cardiovascular outcomes in the USA [1] . Reduction of these outcomes attributable to hypertension is partly dependent on the use of a reliable and valid method to assess blood pressure (BP) control. The most convenient and widely used method is BP measurement in an office setting, but ambulatory blood pressure monitoring (ABPM) has become more common, as increasing evidence suggests that ABPM is a better predictor of BP-related cardiovascular and renal outcomes than office measurements [2] . The US Preventive Services Task Force recommends that ABPM should be considered the reference standard to confirm hypertension in adults [3] .
Despite widespread acceptance of the importance of ABPM in the initial diagnosis of hypertension, subsequent clinical decisions on the efficacy of antihypertensive treatment are often based on office BP alone. Several factors could explain why ABPM is used less often to monitor response to therapy, including convenience, limited access to the equipment and trained personnel, patient acceptance, and cost to patients or third party payers. No guidelines currently recommend the routine use of ABPM for follow-up of primary hypertension management. There are limited data in pediatrics to assess whether the added time, cost, and effort of an ABPM would make any meaningful difference in hypertension management compared with using office BP alone [4] [5] [6] [7] .
Using ABPM as the reference standard for BP assessment, we investigated whether reliance on office BP measurements alone would have resulted in significantly different management decisions in older children with primary hypertension. We utilized data from a cohort of hypertensive children enrolled in a quality improvement study, which provided repeated 24-h ABPMs with concurrent office BP measurements. We investigated whether factors such sex, age, race, BMI, and current antihypertensive medication could predict the difference between the two measurement methods. We also tested whether this difference is consistent within a patient in repeated studies over time (e.g. a patient who exhibited masked uncontrolled hypertension at their first visit might show a predictably similar effect at subsequent visits).
Participants and methods
Data from a series of n-of-1 trials of antihypertensive medications were examined to assess the agreement between office and ambulatory BP. A detailed protocol was published previously [8] .
The ABPM (Ultralite 90217; Spacelabs Healthcare, Issaquah, Washington, USA) [9] was worn on the nondominant arm, with BP measured every 30 min over a 24-h period. Patient-reported sleep times were used to define awake and sleep periods. Only those recordings with at least one reading per hour for a minimum of 18 h were considered adequate and included in this analysis. Ambulatory hypertensive status was defined as follows for the purpose of this study: normal if both wake and sleep mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) were less than the sex/height-based 95th percentile and ambulatory hypertension if either wake or sleep mean SBP or DBP of at least 95th percentile [10, 11] . Adult cutoffs were used for patients aged 18 years and older [12] .
At the conclusion of the 24-h ABPM, the monitor was removed and downloaded at a clinic visit, and office BP was measured by one of the investigators or a nephrology nurse blinded to the ABPM measurements. Using an automated oscillometric device (Spot Vital Signs LXi; Welch Allyn, Skaneateles Falls, New York, USA) [13] , four measurements were taken one minute apart on the right upper extremity using an appropriately sized cuff, with the patient seated and quiet according to fourth report recommendations [14] . The second through fourth readings were averaged to determine the office BP for that visit. For the purposes of this study, normal was defined as SBP and DBP less than 95th percentile, and office hypertension if either SBP or DBP of at least 95th percentile, or using adult cutoffs for patients aged 18 and older [14, 15] .
The primary outcome was the prevalence of misclassification by office BP, that is, how often the hypertensive status differed in a given visit based on the office BP versus the ambulatory BP. We tested the predictors of misclassification using a mixed effects logistic regression model allowing for random intercepts by patient, thereby accounting for repeated measures within patients. Regardless of treatment status, masked uncontrolled hypertension was used to denote visits characterized by normal office BP but ambulatory hypertension, and white coat effect referred to visits with hypertension by office BP but with normal ambulatory BP.
We also evaluated the paired BP difference, defined as office BP minus ambulatory wake mean BP. Normality assumptions were assessed visually by histograms. In analyzing the predictors of the magnitude of the paired BP difference, we used linear mixed effects models accounting for repeated measures within patients.
All models included the following univariate predictors: sex, age, race, BMI, and current antihypertensive medication. To test the assumption of linearity, BMI and age were included as linear as well as categorical predictors in separate models. Two-sided P values less than 0.05 were considered statistically significant for all tests.
Informed consent was not required, as the n-of-1 trial protocol was classified as a quality improvement activity by the Committee for the Protection of Human Subjects at UTHealth McGovern Medical School based on the primary goal of improved care for the participant, exclusive use of approved and commonly used therapies, and no anticipated increased risk of harm compared with usual care.
Results
From June 2013 until July 2016, 42 adolescents with primary hypertension took part in n-of-1 trials. Table 1 summarizes the patients' baseline characteristics. Threequarters of the patients were obese or overweight, and the most common comorbidities included obstructive sleep apnea, asthma, allergic rhinitis, and dyslipidemia. Seven patients required only a single ABPM, as they were normotensive after being trialed off medication, and therefore did not require repeated visits. Three patients were lost to follow-up after a single visit. Among the 32 patients who completed repeated visits every two weeks to test antihypertensive drug efficacy, ABPM was worn a median of six times per patient (range: 3-8/patient). A total of 175 ABPM recordings were considered adequate as defined in the Methods section and included in the following analysis.
Misclassification of hypertensive status
The hypertensive classification by ABPM was different from the classification by office BP in 38.3% of the visits, κ = 0.20. Masked uncontrolled hypertension occurred in 24.6% of visits, and white coat effect in 13.7% (Table 2) . Office BP showed a 64% sensitivity and 57% sensitivity to correctly identify ambulatory hypertensive status.
The frequency of misclassification varied widely among patients, ranging from 0% (no disagreement between ABPM and office BP) to 100%, median 32.5% (Table 3) . Patients whose first visit was characterized by misclassification had a high frequency of misclassification at subsequent visits (45%), although those with agreement at the first visit also had high rates of misclassification at subsequent visits (25%); odds ratio (OR) = 2.03 and 95% confidence interval (CI): 0. 
Paired difference between office and ambulatory blood pressure
The paired BP difference was calculated for each visit and each patient by subtracting the ambulatory wake mean BP from the office BP. Figure 1 shows the ambulatory SBP was underestimated by office BP by a margin of 10 mmHg in 25% of visits and overestimated in 18% of visits.
Patients whose office SBP overestimated ambulatory wake mean SBP at the first visit were more likely to exhibit persistent overestimation on subsequent visits (OR: 15.24; 95% CI: 1.68-138.17) compared with those with underestimation at first visit. In these patients, the mean paired SBP difference on subsequent visits was + 4.6 mmHg (95% CI: − 0.6-9.8). Younger patients (< 12 years old) had a larger difference between office BP and ABPM compared with older patients. Younger children showed underestimation by office SBP (mean − 7.2 mmHg; 95% CI: − 13.3 to − 1.0), whereas older children did not (mean 0.5 mmHg; 95% CI: − 2.7-3.6). Sex, race, BMI, and current antihypertensive medication were not associated with the magnitude of the difference between office and ambulatory BP.
Discussion
In the present cohort of 42 hypertensive children who underwent repeated ABPM paired with office BP measurements, the office BP resulted in a contradictory diagnosis from the ABPM in 38% of visits. To our knowledge, an analysis of repeated ABPM has never been previously reported in children, and the usefulness of routinely repeated ABPM to assess BP control in hypertensive children has not been tested. We found that the difference between office BP and ABPM at the first visit predicted the magnitude of the difference between the two methods at subsequent visits. Although patients with misclassification at the first visit had a high rate of misclassification at subsequent visits (45%), those with concordant diagnoses at the first visit also experienced misclassification at their subsequent visits (25%). A future study with a larger sample size could provide a more precise estimate of the incremental increase in risk for misclassification at future visits based on whether it occurred at the first visit. These data could help clinicians judge which patients might benefit more from routine use of ABPM to monitor antihypertensive therapy efficacy.
The current study was underpowered to evaluate the effect of patient-specific characteristics on the disagreement between ABPM and office BP. Specifically, univariate analyses did not show that sex, current medication, or BMI were associated with the magnitude of the paired BP difference. Despite the small sample size, we did find a significant difference by race, with black patients showing more misclassification than Hispanics. This finding was unexpected and should be examined further with more races represented.
Ambulatory wake mean SBP was higher than office SBP more often in younger patients compared with those aged 12 years and older, but this did not translate into an increased prevalence of masked uncontrolled hypertension in younger patients. This result may be related to increased activity levels in the ambulatory setting in younger patients, which could result in higher ambulatory BP readings that may not be clinically meaningful.
Previous studies in children observed similar overall rates of disagreement between office and ABPM diagnoses. A retrospective review of children with suspected or known hypertension compared ABPM with casual BP readings (not reported whether auscultatory or oscillometric) and found that in eight of 20 (40%) patients, the management decision based on ABPM was opposite to that predicted by casual BP [4] . A larger, recent retrospective study evaluated the agreement between office BP (auscultatory or oscillometric) and ABPM in 206 pediatric patients who underwent 247 ABPM recordings. Among untreated patients, the office BP resulted in a contradictory diagnosis from the APBM in 45% of recordings [6] . The ESCAPE trial group showed that among 118 treated hypertensives with chronic kidney disease, 30% had discordant diagnoses by office BP (auscultatory) and ABPM (23% with white coat effect and 7% with masked uncontrolled hypertension) [7] .
The main strength of this study was the use of repeated ABPM in children and the large total number of ABPM readings. The study had certain limitations as well, including the use of oscillometric measurements to determine office BP. There are some data to suggest that automated oscillometric measurement in hypertensive adults may correlate better with ABPM than auscultatory BP [17] . However, pediatric normative tables are based on auscultatory measurement, and assessing oscillometric readings according to these tables may be problematic [14] . Another limitation was the racial makeup of our patients, in which white and Asian children were underrepresented. The study was performed in a single center, which may limit the generalizability of the results.
Conclusion
We have shown that the use of office BP to assess hypertensive children on treatment can result in misclassification of BP status. We found that black children may experience more misclassification by office BP, and this should be studied further. Children who showed underestimation or overestimation of ambulatory BP by office BP at the initial visit were more likely to experience the same effect at subsequent visits. Future studies should focus on identifying the factors that predict which children would benefit most from the routine use of ABPM in follow-up visits to monitor efficacy of antihypertensive treatment. Copyright r 2017 Wolters Kluwer Health, Inc. All rights reserved.
